Phase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung Cancer
Clinical trial NCT02580708 · TERMINATED
Trial details
- NCT number
- NCT02580708
- Sponsor
- Clovis Oncology, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-30
- Primary completion
- 2016-05-05
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.